Purpose: During metabolic stone therapy, urine supersaturation decreases in
proportion to pretreatment levels. We gauge the quantitative contribution
of regression to the mean for reducing urine supersaturation from high pret
reatment to lower values during therapy.
Materials and Methods: The 24-hour urine supersaturations for calcium oxala
te, calcium phosphate and uric acid were measured on 2 pretreatment and at
least 1 treatment 24-hour collection for each of the 2,667 patients in 2 ne
tworks and at a university based specialty clinic. Changes in supersaturati
on between the first and second pretreatment collections were an estimate o
f random change and compared to therapeutic changes.
Results: Supersaturations decreased between the first and second pretreatme
nt collections, proportional to the supersaturation in the first collection
. However, the magnitude of this effect was minor compared to therapeutic c
hanges. Also, mean change between pretreatment collections was 0, whereas m
ean change with therapy was greater than 0 for all 3 supersaturations.
Conclusions: Although regression to the mean can be detected, it cannot be
responsible for the decrease in urine supersaturation with therapy or the f
act that the decrease is proportional to pretreatment mean supersaturation.
The mechanisms responsible for proportional reduction remain to be clarifi
ed.